Journals / The Anatolian Journal of Cardiology / 2017 / Cilt: 17 - Sayı: 2

Investigation of the arterial stiffness and associated factors in patients with familial Mediterranean fever

Pages
132–138
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The impaired arterial stiffness is correlated to the severity of the inflammatory state rather than to the attack type or genetic mutations

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Because of the ongoing and recurring inflammatory state in familial Mediterranean fever (FMF), patients may experience a high risk of cardiovascular events.
📊
Key Findings & Data:Our aim was to investigate the arterial stiffness and associated factors in patients with FMF.Methods: Sixty-nine consecutive FMF patients (including 11 females) and 35 controls (including 5 females) were enrolled in the study.
💡
Conclusion & Impact:The impaired arterial stiffness is correlated to the severity of the inflammatory state rather than to the attack type or genetic mutations
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Because of the ongoing and recurring inflammatory state in familial Mediterranean fever (FMF), patients may experience a high risk of cardiovascular events. Our aim was to investigate the arterial stiffness and associated factors in patients with FMF.Methods: Sixty-nine consecutive FMF patients (including 11 females) and 35 controls (including 5 females) were enrolled in the study. The demographical, clinical, and laboratory data and genetic mutations of the patients were recorded. In the study, FMF patients according to the Tel-Hashomer criteria were included, whereas patients with other known inflammatory rheumatologic disease, atherosclerotic cardiovascular disease, hypertension, diabetes, those under the age of 18 years, or those refusing to participate in the study were excluded. Arterial stiffness measurements were performed using the TensioMed device (TensoMed Ltd, Budapest, Hungary).Results: The patient and control groups were similar in terms of the mean ages, BMIs, gender, systolic blood pressures, and smoking. FMF patients had a higher pulse wave velocity (PWV) (7.73±1.3 and 7.18±1.1 m/s; p=0.03) and lower brachial and aortic augmentation indexes (–64.6±14.6% and –54.6±25.9%, p=0.041 and 4.9±7.4% and 14.0±11.5%, p=0.025, respectively) compared with the controls. Thirty-one (45%) patients were in the “during-attack” state and had higher PWV (8.17±1.6 and 7.38±0.9 m/s; p=0.027) compared with the asymptomatic patients. PWV was correlated to serum CRP, WBC, ESR, fibrinogen, and neutrophil/lymphocyte ratios (r=0.666, 0.429, 0.441, 0.388, and 0.460, respectively). The genetic mutation and predominant attack type had no effect on arterial stiffness.Conclusion: FMF patients have increased arterial stiffness during attacks compared with asymptomatic patients and controls. The impaired arterial stiffness is correlated to the severity of the inflammatory state rather than to the attack type or genetic mutations

🔖

Cite This Article

ÇAKAR, M., AKHAN, M., DOĞAN, T., TAŞKIN, G., ÖZTÜRK, K., ÇINAR, M., ARSLAN, E., YILMAZ, S. (2017). Investigation of the arterial stiffness and associated factors in patients with familial Mediterranean fever. The Anatolian Journal of Cardiology, Cilt: 17 - Sayı: 2, 132–138. https://ajindex.com/articles/366718

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Bailliere’s Best Pract Res Clin Rheumatol 2000; 14: 477-98
  2. Özen S. Familial mediterranean fever: revisiting an ancient disease. Eur J Pediatr 2003; 162: 449-54
  3. Bhat A, Naguwa SM, Gershwin ME. Genetics and new treatment modalities for familial Mediterranean fever. Ann N Y Acad Sci 2007; 1110: 201-8
  4. Yılmaz S, Çınar M, Şimşek I, Erdem H, Pay S. Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever. Rheumatology 2015; 54: 564-5
  5. Portincasa P. Colchicine, biologic agents and more for the treatment of familial mediterranean fever. The old, the new, and the rare. Curr Med Chem 2016; 23: 60-86
  6. Kasifoğlu T, Bilge SY, Sarı I, Solmaz D, Senel S, Emmungil H, et al. Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology 2014; 53: 741-5
  7. Kostis JB, Lawrence-Nelson J, Ranjan R, Wilson AC, Kostis WJ, Lacy CR. Association of increased pulse pressure with the development of heart failure in SHEP. Systolic Hypertension in the Elderly (SHEP) Cooperative Research Group. Am J Hypertens 2001; 14: 798- 803
  8. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159- 219
  9. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673-8
  10. Kharbanda RK, Deanfield JE. Functions of the healthy endothelium. Coron Artery Dis 2001; 12: 485-91
  11. Yılmaz MI, Sönmez A, Sağlam M, Güleç M, Kılıç S, Eyileten T, et al. Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease. Kidney Int 2009;75:1316-21
  12. Krantz MJ, Long CS, Hosokawa P, Karimkahani E, Dickinson M, Estacio RO, et al. Pulse wave velocity and carotid atherosclerosis in White and Latino patients with hypertension. BMC Cardiovascular Disorders 2011; 11: 15
  13. Tanındı A, Erkan AF, Alhan A, Töre HF. Arterial stiffness and central arterial wave reflection are associated with serum uric acid, total bilirubin, and neutrophil-to-lymphocyte ratio in patients with coronary art